Literature DB >> 18227525

Left ventricular ejection fraction and cardiotoxicity: is our ear really to the ground?

Michael S Ewer, Daniel J Lenihan.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18227525     DOI： 10.1200/JCO.2007.14.8742

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  55 in total

Review 1.  Cardiovascular toxicity of anticancer-targeted therapy: emerging issues in the era of cardio-oncology.

Authors:  Emanuel Raschi; Fabrizio De Ponti
Journal:  Intern Emerg Med       Date:  2011-12-13       Impact factor: 3.397

Review 2.  Echocardiographic evaluation of cardiac function after cancer chemotherapy.

Authors:  Tomoko Negishi; Kazuaki Negishi
Journal:  J Echocardiogr       Date:  2017-07-11

3.  Characterization of the Changes in Cardiac Structure and Function in Mice Treated With Anthracyclines Using Serial Cardiac Magnetic Resonance Imaging.

Authors:  Hoshang Farhad; Pedro V Staziaki; Daniel Addison; Otavio R Coelho-Filho; Ravi V Shah; Richard N Mitchell; Balint Szilveszter; Siddique A Abbasi; Raymond Y Kwong; Marielle Scherrer-Crosbie; Udo Hoffmann; Michael Jerosch-Herold; Tomas G Neilan
Journal:  Circ Cardiovasc Imaging       Date:  2016-12       Impact factor: 7.792

4.  Prolonged electromechanical delay as an early predictor of trastuzumab-induced cardiotoxicity in patients undergoing treatment for breast cancer.

Authors:  Jeong Cheon Choe; Jung Hyun Choi; Jong Hyun Choi; Jinhee Ahn; Jin Sup Park; Hye Won Lee; Jun-Hyok Oh; Han Cheol Lee; Kwang Soo Cha; Taek Jong Hong
Journal:  Clin Cardiol       Date:  2018-10-16       Impact factor: 2.882

5.  Paediatric cardio-oncology: epidemiology, screening, prevention, and treatment.

Authors:  Eric J Chow; Kasey J Leger; Neel S Bhatt; Daniel A Mulrooney; Colin J Ross; Sanjeev Aggarwal; Neha Bansal; Matthew J Ehrhardt; Saro H Armenian; Jessica M Scott; Borah Hong
Journal:  Cardiovasc Res       Date:  2019-04-15       Impact factor: 10.787

6.  Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy.

Authors:  Tomas G Neilan; Otavio R Coelho-Filho; Ravi V Shah; Jiazuo H Feng; Diego Pena-Herrera; Damien Mandry; Francois Pierre-Mongeon; Bobak Heydari; Sanjeev A Francis; Javid Moslehi; Raymond Y Kwong; Michael Jerosch-Herold
Journal:  Am J Cardiol       Date:  2012-12-08       Impact factor: 2.778

7.  Anthracycline cardiotoxicity: from bench to bedside.

Authors:  Luca Gianni; Eugene H Herman; Steven E Lipshultz; Giorgio Minotti; Narine Sarvazyan; Douglas B Sawyer
Journal:  J Clin Oncol       Date:  2008-08-01       Impact factor: 44.544

8.  Assessing the Cardiac Toxicity of Chemotherapeutic Agents: Role of Echocardiography.

Authors:  Timothy C Tan; Marielle Scherrer-Crosbie
Journal:  Curr Cardiovasc Imaging Rep       Date:  2012-12-01

9.  Prevalence of anthracycline-related cardiac dysfunction in long-term survivors of adult-onset lymphoma.

Authors:  Saro H Armenian; Luc Mertens; Cameron Slorach; Kalyanasundaram Venkataraman; Kristen Mascarenhas; Nitya Nathwani; F Lennie Wong; Stephen J Forman; Smita Bhatia
Journal:  Cancer       Date:  2017-11-07       Impact factor: 6.860

10.  Evaluation of sub-acute changes in cardiac function after cisplatin-based combination chemotherapy for testicular cancer.

Authors:  R Altena; E C de Haas; J Nuver; C A J Brouwer; M P van den Berg; A J Smit; A Postma; D Th Sleijfer; J A Gietema
Journal:  Br J Cancer       Date:  2009-05-19       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.